The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Julius Zorn sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Julius Zorn is a medical equipment company that specializes in compression therapy. The company’s product portfolio includes compression garments, supports for ankle, knee, hand, elbow, and orthoses products. Its compression garments are useful in vein treatment, oedema therapy, scar therapy, and donning and doffing aids. Juzo is headquartered in Aichach, Aichach-Friedberg, Germany. Key subsidiaries of Julius Zorn include Julius Zorn.
The key metrics of Julius Zorn related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Julius Zorn is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Julius Zorn.
For a detailed understanding of the performance of Julius Zorn, buy the report here.